MEIJI Holdings Co., Ltd. Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 5/16/2026)
| Balance Sheet | Total Assets | 1,261,759,000,000.00 | ROE | 61.23 % |
| Balance Sheet | Total Equity | 772,587,000,000.00 | ROA | 2.78 % |
| Cashflow | Capital Expenditures | -103,750,000,000.00 | P/FCF | -24.24 |
| Cashflow | Free Cash Flow | -47,228,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 56,522,000,000.00 | P/CF | 20.26 |
| Income | Earnings per Share (diluted) | 129.49 | Div. Yield | 2.42 % |
| Income | Net Income | 35,077,000,000.00 | P/E | 32.64 |
| Income | Shares Outstanding | 270,882,000.00 | P/B | 1.48 |
| Income | Total Revenue | 1,173,688,000,000.00 | P/S | 0.98 |
Ratios calculated on: 10/14/2026
Company Description
MEIJI Holdings Co., Ltd. is a holding company engaged in the manufacture and sale of dairy products, sweets, health foods and medicines. The Company operates through two business segments. The Food segment provides market milk, milk powder, condensed milk, butter, cheese, ice cream, beverages and livestock products, sweets, sugar, health foods and generic pharmaceutical products. The Pharmaceuticals segment provides ethical pharmaceuticals, agricultural chemicals and animal drugs. As of March 31, 2014, the Company had 71 subsidiaries and 16 associated companies.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.meiji.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more